Key facts
- This page summarizes David Thomson's Form 4 filing for MANNKIND CORP (MNKD).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 May 2023, 21:00.
David Thomson - 22 May 2023 Form 4 Insider Report for MANNKIND CORP (MNKD)
- Reporting relationship
- EVP Genl Counsel & Secretary
- Issuer ticker
- MNKD
- Reported as of
- 22 May 2023
- Net transaction value
- +$120,272
- SEC form
- 4
- Accepted by SEC
- 24 May 2023, 21:00:29 UTC
- Prior SEC filing
- 19 May 2023
- Next SEC filing
- 26 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Thomson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Thomson filed Form 4 for MANNKIND CORP (MNKD) on 24 May 2023.
Change
- Previous filing in this sequence was filed on 19 May 2023.
- Current net transaction value: +$120,272.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MNKD
transaction
Common Stock, $.01 Par Value
Award
- Transaction value
- $1,916,000
- Shares
- +400,000
- Change %
- +56%
- Price
- $4.79
- Shares after
- 1,112,253
- Date
- 22 May 2023
- Ownership
- Direct
- Footnotes
- F1
MNKD
transaction
Common Stock, $.01 Par Value
Tax liability
- Transaction value
- $1,347,973
- Shares
- -281,414
- Change %
- -25%
- Price
- $4.79
- Shares after
- 830,839
- Date
- 22 May 2023
- Ownership
- Direct
- Footnotes
- F2
MNKD
transaction
Common Stock, $.01 Par Value
Sale
- Transaction value
- $447,754
- Shares
- -95,576
- Change %
- -12%
- Price
- $4.68
- Shares after
- 735,263
- Date
- 24 May 2023
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
A previously reported restricted stock unit award granted on August 27, 2020 vested on May 22, 2023 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on May 22, 2023 was not less than the closing price on August 27, 2020 and (ii) the percentile ranking of MannKind's total shareholder return (TSR) over the period from August 27, 2020 to May 22, 2023 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period was greater than the 90th percentile. As a result, the performance objective was achieved at 300% of target, resulting in a total share delivery of 600,000 shares. The acquisition of 200,000 shares pursuant to the restricted stock award was reported in Table I of the Form 4 filed by the Reporting Person on August 31, 2020.
Footnote F2
Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units.
Footnote F3
Transaction occurred pursuant to Rule 10B5-1 Plan.